Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma
Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma have?
Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma has 438 citations in the OpenAlex counts ScholarIQ stores.
When was Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma published?
Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma has 2012 year in the ScholarIQ index.
What is the open-access status of Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma?
Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma has bronze oa status in the ScholarIQ index.
What is the DOI of Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma?
The DOI for Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma is on the source record.
What is the PMID of Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma?
The PMID for Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma is on the source record.
What is the OpenAlex record for Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma?
The OpenAlex for Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma is on the source record.